Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,095
Closed -$358K 358
2025
Q4
$358K Buy
+1,095
New +$347K 0.07% 284
2025
Q1
Sell
-2,067
Closed -$539K 279
2024
Q4
$539K Sell
2,067
-2,606
-56% -$773K 0.23% 161
2024
Q3
$1.51M Buy
+4,673
New +$1.53M 0.6% 47
2024
Q2
Sell
-1,100
Closed -$313K 263
2024
Q1
$313K Buy
+1,100
New +$322K 0.16% 201
2023
Q3
Sell
-4,350
Closed -$966K 262
2023
Q2
$966K Buy
4,350
+1,550
+55% +$360K 0.55% 58
2023
Q1
$677K Buy
+2,800
New +$687K 0.59% 42
2019
Q4
Sell
-11,021
Closed -$2.13M 341
2019
Q3
$2.13M Buy
+11,021
New +$2.12M 0.97% 11
2019
Q2
Sell
-3,806
Closed -$723K 491
2019
Q1
$723K Buy
+3,806
New +$727K 0.29% 125

Other funds holding AMGN

Machina Capital's AMGN Position: Q1 2026 in Review

Machina Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,095 shares — an estimated $358K sold.

Machina Capital first reported a position in AMGN in Q1 2019 and held it in 8 quarters. The position peaked at $2.13M in Q3 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Machina Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Machina Capital sold 1,095 Amgen shares in Q1 2026, an estimated $358K.
  • Machina Capital first reported a position in Amgen in Q1 2019 and held it in 8 quarters.
  • Machina Capital's Amgen position peaked at $2.13M in Q3 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Machina Capital's 13F filing for Q1 2026, filed 13 May 2026.